Pediatrix Medical Group, Inc.
NYSE:MDMedical - Care Facilities
-$0.48 today
- Market cap
- $2.41B
- Beta
- 0.70
- P/E (TTM)
- 11.0
- EPS (TTM)
- $2.10
Volume 0.64M
Average 0.82M
MD Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Pediatrix Medical Group, Inc.NYSE: MD
Property, Plant & Equipment (Net) · Q3 FY2026 · quarter ended Sep 2026
Property, plant & equipment (net) falls 4.6% from a year ago
Property, plant & equipment (net) stood at $70.95M at the end of Q3 FY2026, down 4.6% from a year earlier and down 4.0% from the prior quarter. Over 3 fiscal years it compounded at -19.4% a year.
Context
- Property, plant & equipment (net) amounted to 3.3% of total assets at the end of Q3 FY2026, unchanged from a year earlier.
- Property, plant & equipment (net) increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -4.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 73.51M USD
- Year-over-year change
- -6.3%
- 4-year CAGR
- -14.2%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 73.51M | -6.3% |
| FY2024 | 2024-12-31 | 78.44M | -46.2% |
| FY2023 | 2023-12-31 | 145.93M | +4.1% |
| FY2022 | 2022-12-31 | 140.21M | +3.4% |
| FY2021 | 2021-12-31 | 135.62M | — |
Property, Plant & Equipment (Net) vs competitors
How MD compares with its peers on the latest reported figures
- MD's Sep 2026 property, plant & equipment (net) of $70.95M is the 9th highest of the 11 companies compared; the peer median is $803.85M.
- Its year-over-year change of -4.6% is the 10th highest of 11, against a peer median of +3.3%.
- Property, plant & equipment (net) amounts to 3.3% of total assets for MD, versus a peer median of 17.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $3.19B | -0.6% | +15.8% | 57.4% | |
ARDTArdent Health Partners, LLC | Mar 2026 | $2.14B | +3.8% | +2.5% | 40.8% |
| Mar 2026 | $2.04B | +13.1% | -3.5% | 33.8% | |
| Sep 2026 | $1.31B | +78.7% | — | 63.2% | |
| Sep 2026 | $1.29B | -0.3% | +1.9% | 9.6% | |
| Jun 2026 | $321.7M | +5.9% | -7.5% | 14.7% | |
| Mar 2026 | $93.48M | +96.6% | -9.9% | 4.0% | |
GRDNGuardian Pharmacy Services, Inc. | Jun 2026 | $88.89M | +2.8% | +11.4% | 20.0% |
| Sep 2026 | $70.95M | -4.6% | -19.4% | 3.3% | |
| Jun 2026 | $64.89M | -7.8% | +4.5% | 4.5% | |
| Oct 2026 | $55.52M | +0.5% | -10.4% | 2.5% | |
| Peer median (excluding MD) | $803.85M | +3.3% | +1.9% | 17.4% | |
Competitors are the stored peer set for MD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 387.39M | 9.82M | 73.26M | 229.94M | 375.24M |
| Short-term Investments | 99.72M | 93.24M | 104.49M | 118.57M | 124.48M |
| Net Receivables | 316.02M | 296.79M | 279.88M | 272.6M | 242.31M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 18.9M | 13.26M | 12.31M | 5.09M | 8.88M |
| Total Current Assets | 840.56M | 427.99M | 483.45M | 639.61M | 763.51M |
| Property, Plant & Equipment (Net) | 135.62M | 140.21M | 145.93M | 78.44M | 73.51M |
| Goodwill | 1.51B | 1.53B | 1.38B | 1.24B | 1.26B |
| Intangible Assets | 21.57M | 18.49M | 21.24M | 11.6M | 16.86M |
| Long-term Investments | 0 | 0 | 0 | 0 | 20.8M |
| Tax Assets | 88.34M | 105.93M | 102.85M | 103.86M | 73.92M |
| Other Non-current Assets | 131.03M | 123.18M | 82.17M | 76.6M | 37.36M |
| Total Non-current Assets | 1.88B | 1.92B | 1.74B | 1.51B | 1.48B |
| Total Assets | 2.72B | 2.35B | 2.22B | 2.15B | 2.25B |
| Account Payables | 36.65M | 31.86M | 34.59M | 46.43M | 37.22M |
| Short-term Debt | 0 | 12.5M | 12.5M | 18.75M | 38.4M |
| Tax Payables | 46.07M | 51.25M | 38.7M | 37.62M | 984K |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 94.63M |
| Total Current Liabilities | 427.37M | 426.98M | 388.95M | 434.11M | 458.91M |
| Long-term Debt | 1B | 627.65M | 611.59M | 593.57M | 594.64M |
| Deferred Tax Liabilities | 41.41M | 33.64M | 34.31M | 34.25M | 57.02M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 313.43M | 315.04M | 281.84M | 290.34M | 243M |
| Total Non-current Liabilities | 1.4B | 1.03B | 981.8M | 953.65M | 921.93M |
| Total Liabilities | 1.83B | 1.46B | 1.37B | 1.39B | 1.38B |
| Common Stock | 864K | 829K | 840K | 859K | 830K |
| Retained Earnings | (155.39M) | (89.06M) | (149.47M) | (248.54M) | (83.15M) |
| Accumulated OCI | 1.32M | (3.74M) | (2.21M) | (1.07M) | 610K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 205K | 0 | 0 | 0 | 0 |
| Total Equity | 896.69M | 891.63M | 849.06M | 764.94M | 865.85M |
| Total Debt | 1.07B | 717.08M | 701.65M | 662.31M | 660.3M |
| Net Debt | 678.44M | 707.26M | 628.39M | 432.37M | 285.06M |
Pediatrix Medical Group, Inc.
NYSE:MD
Intrinsic Alpha fair value
Locked
Current Price
$30.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.